News

The single-site trial is enrolling healthy normal volunteers in a double-masked, placebo-controlled, single ascending-dose study to evaluate the safety, tolerability and pharmacokinetics of ACU-02. ACU-02 is an orally

Amicus is initiating the multi-national, open-label Phase II clinical trial designed to enroll 18 adult patients diagnosed with Pompe disease. The primary objective of the study is to

Potassium-Chloride is the generic equivalent to KV Pharmaceutical’s Micro-K Extencaps USP and is indicated for the treatment of patients with hypokalemia, with or without metabolic alkalosis, in digitalis

This agreement provides Merck with access to GeneGo’s content through MetaBase which includes access to MetaCore and MetaDrug content and GeneGo’s internal database of disease biomarkers. Julie Bryant,

Under the terms of the agreement, Oryx’s shareholders received $50 million (approximately 2.5 times projected 2008 sales) and may become entitled to receive subsequent payments up to $20

Dr Steiner brings with him a vast array of proven management and business skills. After establishing a private medical practice in 1983, Mr Steiner served as a medical

The Phase I/II safety and tolerability study in 18 male patients with non-metastatic as well as hormone-insensitive prostate cancer has begun enrolment in the US. Secondary objectives of

Invitrogen’s DynaChip antibody analysis system is said to provide fully integrated instrumentation, reagents and software for automated detection and identification of human leukocyte antigen antibodies. Kip Miller, senior

Under the terms of the agreement with Ferring, Ferring will fund development of a custom version of the OmniPod’s Personal Diabetes Manager and, upon completion of the development,